GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Churchill Capital Corp XI CCXI · USD

Health Care · US listing · 🇺🇸 United States

Compare

11.26

+5.33%

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2014FY2025

Net income

$382,098

FY2014FY2025

Free cash flow

−$632,848

FY2014FY2025

Shareholders' equity

$399.8m

FY2014FY2025

Income statement

Fiscal years

FY2025FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue—$32.2m$64.9m$36.1m$42.9m$82.5m$11.9m——
Gross profit—$31.9m———————
Research and development—$83.0m$77.9m$70.3m$62.7m$49.5m$38.0m$33.2m$33.8m
Operating income−$167,685−$129.9m−$55.2m−$58.3m−$40.3m$16.5m−$40.7m−$47.7m−$47.4m
Net income$382,098−$131.8m−$55.4m−$55.5m−$38.0m$17.9m−$40.0m−$47.3m−$46.9m
Diluted earnings per share0.01-1.89-0.84-0.98-0.760.36-0.86-1.08-1.08

Balance sheet

At each fiscal year end

FY2025FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$415.9m$425.7m$518.9m$209.1m$183.3m$189.3m$155.9m$78.2m$117.0m
Cash and short-term investments$736,204$264.5m$436.6m$172.8m$177.0m$127.3m$117.8m$71.3m$73.4m
Total liabilities$16.1m$139.5m$133.3m$143.1m$168.6m$110.1m$106.0m$5.6m$8.4m
Debt—$23.6m$24.4m$19.8m$19.7m$4.7m———
Shareholders' equity$399.8m$286.1m$385.6m$66.0m$14.7m$79.3m$49.9m$72.5m$108.6m
Shares outstanding56m70m66m57m50m50m46m44m43m

Cash flow

Fiscal years

FY2025FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$632,844−$75.6m−$81.1m−$70.1m$16.4m$4.9m$39.1m−$39.3m−$34.3m
Capital spending−$4−$19.0m−$15.4m−$790,000−$840,000−$720,000−$300,000−$220,000−$350,000
Free cash flow−$632,848−$94.6m−$96.5m−$70.9m$15.6m$4.2m$38.9m−$39.5m−$34.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Jun 2022Mar 2022Dec 2021
Revenue—————$11.8m$5.5m$2.3m
Gross profit—————$11.0m$5.3m$2.0m
Operating income−$39.8m−$9,556−$116,756−$50,929−$22,045−$31.6m−$38.2m−$40.1m
Net income−$134.7m$81,109$433,027−$28,884−$22,045−$31.7m−$38.6m−$40.5m
Diluted earnings per share-2.420.000.01-0.00-0.00-0.44-0.55-0.58
Cash from operations—————−$26.0m$8.0m−$10.0m
Total assets$422.6m$10.3m$415.9m$209,830$64,506$419.4m$440.5m$425.7m
Cash and short-term investments$1.3m$10,089$736,204——$328.6m$340.6m$264.5m
Debt—————$4.0m$4.6m$4.7m
Shareholders' equity$268.3m$9.9m$399.8m−$25,929$2,955$236.5m$258.7m$286.1m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-85.8%—-42.1%
Net income—-53.6%—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.